On Holding Stock Falls 30% in Three Months: Time to Buy or Stay Away?

On Holding shares have fallen 30.2% over the past three months and trade 46.8% below their January 2026 high, pressured by slowing Americas wholesale demand and management's deliberate reduction of wholesale sell-in. Q2 Americas sales rose only 4.5% and wholesale sales increased 4.8%, while full-year constant-currency growth is projected in the low-20% range, or CHF 3.47B-CHF 3.56B, with growth weighted toward Q4. Consensus EPS estimates fell by $0.03 to $0.47 for the current quarter and by $0.02 to $0.37 for the next quarter; despite DTC reaching CHF 388.4M and 45.7% of sales, Zacks rates ONON Sell amid valuation, execution and geopolitical risks.

Analysis

ONON’s key issue is not simply slower growth; it is a channel-reset problem occurring while the company still carries a premium brand multiple. Restricting wholesale shipments can preserve gross margin and avoid retailer markdowns, but it shifts the burden to DTC at a point when store openings, digital acquisition and brand marketing require higher operating investment. Unless Americas sell-through improves by the spring buying cycle, consensus is likely still too high on the pace of margin expansion as fixed retail and marketing costs are absorbed over lower wholesale volume.

The more important read-through is competitive: promotional pressure in multi-brand running is likely to favor scaled, broadly distributed incumbents such as DECK (Hoka) and NKE, which can use inventory, marketing budgets and wholesale relationships to defend shelf space. It is less directly negative for ANF and URBN: their strength is driven by fashion/product-cycle execution and controlled inventories rather than performance-running replenishment. A sustained ONON de-risking would also raise the bar for premium-growth apparel/footwear valuations generally, particularly names dependent on wholesale expansion.

Near term, the October product cycle is a sentiment catalyst but not proof of a wholesale recovery; initial specialty-channel demand can be strong while broader replenishment remains weak. The market may be underestimating the value of management protecting full-price architecture: if channel inventory normalizes by 1Q27, ONON can reaccelerate with cleaner gross margins than a promotional recovery would permit. That is a 6-18 month optionality argument, not a reason to front-run the next earnings print while estimates continue to fall.

The bearish thesis is falsified by sequential acceleration in Americas wholesale orders and stable-or-improving gross margin despite lower sell-in. Conversely, another guidance reset, elevated promotions at key wholesale accounts, or DTC growth decelerating below wholesale shortfall would expose a further valuation reset toward more mature footwear multiples.

Key Decisions for Investors

• Maintain an underweight/short bias in ONON into the next earnings and 1-3 month wholesale-order update; use a close above the 50-day moving average combined with upward EPS revisions as a cover trigger. The asymmetric risk is a product-launch-driven squeeze, so size modestly or express via put spreads rather than outright short stock.
• Pair trade for the next 3-6 months: long ANF / short ONON, dollar-neutral. ANF has stronger current estimate momentum and lower valuation sensitivity, while ONON must demonstrate a credible Americas channel recovery; exit if ONON reports clear sequential wholesale acceleration and ANF inventory or margin guidance deteriorates.
• Do not initiate a fundamental long in ONON solely on the drawdown. Add to a watchlist for a 6-18 month recovery only after two conditions are independently visible: stabilization in Americas wholesale sell-through/reorders and no material gross-margin dilution from DTC investment.
• Monitor DECK and NKE earnings commentary on U.S. run-specialty inventory and promotional activity as leading indicators. Broad evidence of clean running-footwear inventory would improve the ONON recovery setup; continued discounting would support the short/pair thesis.